Tracy Roy Bloom, NP
Nurse Practitioner · Napa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 26 years
- Graduated 2000
Offices
1 location · Providence Medical Foundation · 1,461 clinicians in this group
Hospitals listed: 057517 · 057659 · Providence Queen of the Valley Medical Center · Sonoma Valley Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Tracy Roy Bloom’s office at (707) 253-7161 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Queen of the Valley Medical CenterNapa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.107, Oct 2024 – Sep 2025
- Sonoma Valley HospitalSonoma, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Providence Queen of the Valley Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.107 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.92) · 609 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.5 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.43 (130.54 to 252.33) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 175 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.41) · 4,152 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,188 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (1.63 to 5.99) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.21) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.62 to 3.77) · 742 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.45 (0.91 to 16) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.58 (1.75 to 9.42) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 2,994 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.684 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.887 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.8 · 143 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.1 · 316 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1 · 399 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.4 · 337 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.5 to 7.8) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (9.8 to 17.7) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.2) · 848 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 423 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Sonoma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.63 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.6 · 345 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 713 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.94) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 60 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.2 to 17.9) · 486 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 83 cases | No different | Jan 2024 – Dec 2024 |
What patients said (164 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$68,872
Medicare paid this office $68,872 for 387 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 262 | $39,809 | $82 |
| Short return visit (20+ min) | 147 | $11,451 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 66 | $8,284 | $126 |
| Influenza vaccine, inactivated | 24 | $1,964 | $82 |
| Short return visit | 32 | $1,346 | $37 |
See all 10 services
| Return visit (30+ min) | 262 | $39,809 | $82 |
| Short return visit (20+ min) | 147 | $11,451 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 66 | $8,284 | $126 |
| Influenza vaccine, inactivated | 24 | $1,964 | $82 |
| Short return visit | 32 | $1,346 | $37 |
| New patient visit (30+ min) | 19 | $1,277 | $67 |
| Administration of influenza virus vaccine | 26 | $951 | $37 |
| Hemoglobin a1c level | 19 | $219 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $215 | $10 |
| Removal of impacted ear wax by washing | 12 | $158 | $13 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax by washing | – | – | – | – | – | 12 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
387 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 14% · Women 65% · Also on Medicaid 13% · Health risk score 1.08. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 74% · Diabetes 25% · Coronary heart disease 24% · Chronic kidney disease 20% · Atrial fibrillation 19% · Depression 18% · Cancer 17% · Heart failure 12% · Stroke 12% · COPD 10% · Dementia 7%.
The office billed $331,926, Medicare allowed $96,121 and paid $68,872; for 1,051 services of 40 kinds; $3,272 of it was for drugs given in the office and $65,600 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 387 | 1,051 | 76 | 1.08 | $331,926 | $68,872 |
| 2023 | 438 | 977 | 76 | 1.21 | $270,279 | $69,201 |
| 2022 | 401 | 962 | 76 | 1.17 | $257,082 | $68,859 |
| 2021 | 335 | 992 | 76 | 1.23 | $152,963 | $72,371 |
| 2020 | 343 | 999 | 76 | 1.25 | $144,573 | $60,332 |
| 2019 | 20 | 40 | 75 | 1.30 | $4,213 | $1,697 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 270 | $39,560 | $85 |
| Short return visit (20+ min) | 131 | $9,588 | $59 |
| Telephone medical discussion with physician, 11-20 minutes | 76 | $5,792 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $3,689 | $123 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,136 | $82 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 17 | $1,289 | $76 |
| New patient visit (30+ min) | 19 | $1,089 | $57 |
| Administration of influenza virus vaccine | 27 | $789 | $29 |
| Short return visit | 18 | $671 | $35 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $575 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $156 | $10 |
2022: 10 services
| Return visit (30+ min) | 219 | $33,393 | $86 |
| Short return visit (20+ min) | 140 | $12,468 | $65 |
| Telephone medical discussion with physician, 11-20 minutes | 109 | $9,571 | $69 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $2,649 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,631 | $125 |
| Telephone medical discussion with physician, 5-10 minutes | 39 | $1,779 | $42 |
| New patient visit (30+ min) | 16 | $1,159 | $72 |
| Administration of influenza virus vaccine | 11 | $322 | $29 |
| Hemoglobin a1c level | 13 | $155 | $10 |
| Urinalysis, manual test | 14 | $59 | $3 |
2021: 10 services
| Return visit (30+ min) | 216 | $39,823 | $90 |
| Short return visit (20+ min) | 182 | $18,396 | $63 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 16 | $2,580 | $161 |
| New patient visit (45+ min) | 16 | $1,836 | $115 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,661 | $128 |
| Influenza vaccine split virus, preservative free | 21 | $1,366 | $65 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $769 | $70 |
| Administration of influenza virus vaccine | 23 | $391 | $17 |
| Hemoglobin a1c level | 20 | $272 | $10 |
| Urinalysis, manual test | 23 | $111 | $3 |
2020: 12 services
| Return visit (30+ min) | 167 | $25,490 | $77 |
| Short return visit (20+ min) | 192 | $15,829 | $50 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 34 | $5,606 | $165 |
| Influenza vaccine split virus, preservative free | 38 | $2,360 | $61 |
| Short return visit | 54 | $2,261 | $40 |
| New patient visit (45+ min) | 13 | $1,273 | $98 |
| Administration of influenza virus vaccine | 46 | $926 | $20 |
| Administration of pneumococcal vaccine | 13 | $255 | $20 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $215 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $160 | $11 |
| Hemoglobin a1c level | 12 | $145 | $10 |
| Urinalysis, manual test | 17 | $69 | $3 |
2019: 1 service
| Short return visit (20+ min) | 15 | $1,197 | $57 |
Drugs they prescribed that Part D paid
$399,284
Pharmacies billed $399,284 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (100 of 4,180) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
3,703 generic and 452 brand-name prescriptions · $399,284 in drug cost · 76 antibiotic prescriptions to 49 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 64 | $81,873 | $1,279 |
| Eliquis | 37 | $43,159 | $1,166 |
| Jardiance | 26 | $42,986 | $1,653 |
| Januvia | 20 | $25,460 | $1,273 |
| Xarelto | 17 | $20,559 | $1,209 |
See all 89 drugs
| Ozempic | 64 | $81,873 | $1,279 |
| Eliquis | 37 | $43,159 | $1,166 |
| Jardiance | 26 | $42,986 | $1,653 |
| Januvia | 20 | $25,460 | $1,273 |
| Xarelto | 17 | $20,559 | $1,209 |
| Premarin | 14 | $9,824 | $702 |
| Nucynta | 11 | $5,203 | $473 |
| Pantoprazole | 82 | $4,880 | $60 |
| Fluticasone-Salmeterol | 11 | $3,640 | $331 |
| Celecoxib | 20 | $2,168 | $108 |
| Atorvastatin | 249 | $2,135 | $9 |
| Omeprazole | 119 | $2,015 | $17 |
| Levothyroxine | 180 | $1,898 | $11 |
| Ondansetron Odt | 30 | $1,808 | $60 |
| Gabapentin | 96 | $1,654 | $17 |
| Losartan | 147 | $1,513 | $10 |
| Hydroxychloroquine Sulfate | 18 | $1,471 | $82 |
| Lantus Solostar | 14 | $1,454 | $104 |
| Fluticasone Propionate | 80 | $1,438 | $18 |
| Lisinopril | 182 | $1,385 | $8 |
| Trazodone | 100 | $1,344 | $13 |
| Albuterol Sulfate Hfa | 47 | $1,311 | $28 |
| Metoprolol | 57 | $1,191 | $21 |
| Valsartan | 40 | $1,185 | $30 |
| Hydrocodone-Acetaminophen | 35 | $999 | $29 |
| Metronidazole | 15 | $908 | $61 |
| Escitalopram | 55 | $891 | $16 |
| Ibandronate | 20 | $890 | $45 |
| Ultra-Fine Mini Pen Needle | 11 | $871 | $79 |
| Metformin | 92 | $845 | $9 |
| Amlodipine Besylate | 167 | $838 | $5 |
| Rosuvastatin | 51 | $778 | $15 |
| Duloxetine | 18 | $661 | $37 |
| Ropinirole | 30 | $635 | $21 |
| Bupropion Xl | 16 | $537 | $34 |
| Diclofenac | 17 | $532 | $31 |
| Tamsulosin | 46 | $521 | $11 |
| Synthroid | 11 | $456 | $41 |
| Olmesartan Medoxomil | 13 | $407 | $31 |
| Simvastatin | 46 | $399 | $9 |
| Hydrochlorothiazide | 80 | $395 | $5 |
| Mirtazapine | 15 | $384 | $26 |
| Irbesartan | 50 | $378 | $8 |
| Estradiol | 13 | $364 | $28 |
| Colchicine | 11 | $350 | $32 |
| Loperamide | 27 | $343 | $13 |
| Eszopiclone | 21 | $341 | $16 |
| Baclofen | 20 | $329 | $16 |
| Glipizide Er | 29 | $305 | $11 |
| Sertraline | 52 | $303 | $6 |
| Metoprolol | 53 | $283 | $5 |
| Paroxetine | 18 | $276 | $15 |
| Fluoxetine | 15 | $271 | $18 |
| Cyclobenzaprine | 32 | $269 | $8 |
| Famotidine | 27 | $250 | $9 |
| Glipizide | 41 | $249 | $6 |
| Rizatriptan | 15 | $228 | $15 |
| Furosemide | 42 | $206 | $5 |
| Triamterene-Hydrochlorothiazid | 19 | $203 | $11 |
| Meloxicam | 19 | $191 | $10 |
| Potassium Chloride | 23 | $190 | $8 |
| Acyclovir | 24 | $187 | $8 |
| Citalopram Hbr | 23 | $175 | $8 |
| Clopidogrel | 18 | $173 | $10 |
| Finasteride | 11 | $170 | $15 |
| Oxycodone | 12 | $170 | $14 |
| Atenolol | 32 | $168 | $5 |
| Ondansetron | 24 | $167 | $7 |
| Alprazolam | 48 | $165 | $3 |
| Montelukast | 15 | $165 | $11 |
| Losartan-Hydrochlorothiazide | 17 | $155 | $9 |
| Alendronate | 13 | $136 | $10 |
| Allopurinol | 16 | $131 | $8 |
| Lamotrigine | 11 | $131 | $12 |
| Ibuprofen | 28 | $127 | $5 |
| Triamcinolone Acetonide | 18 | $126 | $7 |
| Sulfamethoxazole-Trimethoprim | 16 | $124 | $8 |
| Ketoconazole | 13 | $106 | $8 |
| Carvedilol | 26 | $97 | $4 |
| Tizanidine | 15 | $95 | $6 |
| Amoxicillin-Clavulanate Potass | 12 | $92 | $8 |
| Cephalexin | 13 | $88 | $7 |
| Tramadol | 16 | $61 | $4 |
| Clonazepam | 22 | $58 | $3 |
| Benazepril | 21 | $54 | $3 |
| Spironolactone | 12 | $39 | $3 |
| Diazepam | 18 | $35 | $2 |
| Lorazepam | 15 | $23 | $2 |
| Azithromycin | 11 | $19 | $2 |
Year by year
| 2024 | 4,180 | 593 | 2% (100) | 11% | $399,284 |
| 2023 | 3,118 | 487 | 3% (88) | 9% | $265,215 |
| 2022 | 2,484 | 394 | 3% (70) | None | $229,722 |
| 2021 | 1,965 | 282 | 3% (57) | None | $101,834 |
| 2020 | 1,332 | 218 | 3% (44) | None | $62,937 |
| 2019 | 211 | 56 | None | 19% | $17,105 |
| 2018 | 187 | 48 | None | 11% | $11,301 |
| 2017 | 153 | 44 | None | 19% | $11,977 |
| 2016 | 302 | 61 | None | 21% | $15,176 |
| 2015 | 136 | 34 | 0% (0) | 23% | $7,496 |
| 2014 | 93 | 25 | 0% (0) | 15% | $2,348 |
| 2013 | 73 | 22 | 0% (0) | None | $3,314 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 69 drugs
| Eliquis | 20 | $33,347 | $1,667 |
| Ozempic | 24 | $27,954 | $1,165 |
| Symbicort | 16 | $8,260 | $516 |
| Premarin | 14 | $6,235 | $445 |
| Atorvastatin | 200 | $3,784 | $19 |
| Levothyroxine | 115 | $2,530 | $22 |
| Celecoxib | 21 | $2,160 | $103 |
| Trazodone | 72 | $2,113 | $29 |
| Ventolin Hfa | 13 | $1,974 | $152 |
| Omeprazole | 71 | $1,917 | $27 |
| Lisinopril | 123 | $1,887 | $15 |
| Amlodipine Besylate | 149 | $1,776 | $12 |
| Losartan | 104 | $1,687 | $16 |
| Rosuvastatin | 24 | $1,540 | $64 |
| Diclofenac | 28 | $1,512 | $54 |
| Gabapentin | 71 | $1,390 | $20 |
| Valsartan | 29 | $1,376 | $47 |
| Ibandronate | 18 | $1,353 | $75 |
| Duloxetine | 21 | $1,192 | $57 |
| Tamsulosin | 38 | $978 | $26 |
| Metoprolol | 40 | $946 | $24 |
| Pantoprazole | 69 | $910 | $13 |
| Metformin | 63 | $777 | $12 |
| Synthroid | 14 | $776 | $55 |
| Escitalopram | 24 | $736 | $31 |
| Ondansetron Odt | 20 | $722 | $36 |
| Simvastatin | 37 | $690 | $19 |
| Fluticasone Propionate | 37 | $662 | $18 |
| Sertraline | 50 | $661 | $13 |
| Ropinirole | 21 | $639 | $30 |
| Hydrocodone-Acetaminophen | 39 | $619 | $16 |
| Cyclobenzaprine | 46 | $592 | $13 |
| Potassium Chloride | 20 | $588 | $29 |
| Oxcarbazepine | 12 | $529 | $44 |
| Paroxetine | 21 | $508 | $24 |
| Albuterol Sulfate Hfa | 17 | $496 | $29 |
| Irbesartan | 16 | $478 | $30 |
| Mirtazapine | 19 | $476 | $25 |
| Nystatin | 22 | $463 | $21 |
| Hydroxyzine | 15 | $454 | $30 |
| Citalopram Hbr | 25 | $435 | $17 |
| Metoprolol | 38 | $431 | $11 |
| Losartan-Hydrochlorothiazide | 23 | $423 | $18 |
| Atenolol | 35 | $404 | $12 |
| Glipizide | 44 | $396 | $9 |
| Loperamide | 18 | $384 | $21 |
| Hydrochlorothiazide | 66 | $344 | $5 |
| Alprazolam | 49 | $322 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $295 | $25 |
| Allopurinol | 18 | $277 | $15 |
| Clopidogrel | 20 | $274 | $14 |
| Temazepam | 15 | $272 | $18 |
| Tizanidine | 22 | $259 | $12 |
| Carvedilol | 15 | $232 | $15 |
| Oxycodone | 14 | $228 | $16 |
| Furosemide | 31 | $218 | $7 |
| Triamcinolone Acetonide | 26 | $215 | $8 |
| Eszopiclone | 16 | $198 | $12 |
| Ondansetron | 21 | $196 | $9 |
| Clonazepam | 16 | $187 | $12 |
| Acyclovir | 15 | $173 | $12 |
| Prednisone | 13 | $112 | $9 |
| Meclizine | 12 | $111 | $9 |
| Diazepam | 23 | $111 | $5 |
| Ibuprofen | 17 | $105 | $6 |
| Benazepril | 11 | $93 | $8 |
| Sulfamethoxazole-Trimethoprim | 19 | $74 | $4 |
| Topiramate | 11 | $52 | $5 |
| Lorazepam | 13 | $32 | $2 |
2022: 64 drugs
| Eliquis | 15 | $19,349 | $1,290 |
| Symbicort | 11 | $5,276 | $480 |
| Lidocaine | 22 | $3,615 | $164 |
| Rosuvastatin | 27 | $3,007 | $111 |
| Atorvastatin | 158 | $2,656 | $17 |
| Levothyroxine | 88 | $2,252 | $26 |
| Gabapentin | 58 | $2,137 | $37 |
| Losartan | 105 | $1,962 | $19 |
| Lisinopril | 126 | $1,869 | $15 |
| Celecoxib | 13 | $1,766 | $136 |
| Omeprazole | 62 | $1,534 | $25 |
| Metoprolol | 54 | $1,486 | $28 |
| Trazodone | 41 | $1,434 | $35 |
| Ibandronate | 15 | $1,342 | $89 |
| Amlodipine Besylate | 82 | $1,227 | $15 |
| Duloxetine | 13 | $1,164 | $90 |
| Valsartan | 22 | $1,106 | $50 |
| Pantoprazole | 44 | $1,045 | $24 |
| Diclofenac | 20 | $1,040 | $52 |
| Sertraline | 50 | $1,036 | $21 |
| Cyclobenzaprine | 31 | $1,003 | $32 |
| Raloxifene | 11 | $994 | $90 |
| Synthroid | 13 | $907 | $70 |
| Tamsulosin | 32 | $873 | $27 |
| Venlafaxine Hcl Er | 14 | $701 | $50 |
| Metformin | 51 | $680 | $13 |
| Escitalopram | 25 | $624 | $25 |
| Klor-Con 10 | 21 | $613 | $29 |
| Mirtazapine | 14 | $573 | $41 |
| Potassium Chloride | 29 | $562 | $19 |
| Metformin Hcl Er | 16 | $514 | $32 |
| Quetiapine | 12 | $505 | $42 |
| Simvastatin | 40 | $486 | $12 |
| Alprazolam | 36 | $476 | $13 |
| Hydrochlorothiazide | 73 | $411 | $6 |
| Allopurinol | 19 | $390 | $21 |
| Atenolol | 31 | $333 | $11 |
| Fluticasone Propionate | 18 | $308 | $17 |
| Metoprolol | 26 | $286 | $11 |
| Ropinirole | 14 | $284 | $20 |
| Oxycodone | 14 | $275 | $20 |
| Losartan-Hydrochlorothiazide | 13 | $263 | $20 |
| Carvedilol | 16 | $253 | $16 |
| Triamterene-Hydrochlorothiazid | 15 | $251 | $17 |
| Citalopram Hbr | 20 | $242 | $12 |
| Temazepam | 12 | $222 | $19 |
| Furosemide | 43 | $214 | $5 |
| Naproxen | 21 | $209 | $10 |
| Glipizide | 13 | $201 | $15 |
| Acyclovir | 12 | $184 | $15 |
| Hydrocodone-Acetaminophen | 20 | $177 | $9 |
| Meclizine | 15 | $133 | $9 |
| Nitrofurantoin Mono-Macro | 11 | $117 | $11 |
| Alendronate | 11 | $116 | $11 |
| Clonazepam | 19 | $106 | $6 |
| Azithromycin | 11 | $95 | $9 |
| Prednisone | 16 | $92 | $6 |
| Zolpidem | 14 | $88 | $6 |
| Ibuprofen | 17 | $83 | $5 |
| Diazepam | 17 | $80 | $5 |
| Ciprofloxacin | 12 | $69 | $6 |
| Cephalexin | 14 | $57 | $4 |
| Tramadol | 15 | $42 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $32 | $3 |
2021: 56 drugs
| Eliquis | 18 | $23,864 | $1,326 |
| Nucynta | 11 | $3,999 | $364 |
| Atorvastatin | 114 | $1,884 | $17 |
| Levothyroxine | 64 | $1,542 | $24 |
| Metoprolol | 53 | $1,376 | $26 |
| Amlodipine Besylate | 93 | $1,306 | $14 |
| Trazodone | 57 | $1,262 | $22 |
| Celecoxib | 23 | $1,262 | $55 |
| Lisinopril | 91 | $1,217 | $13 |
| Losartan | 68 | $1,132 | $17 |
| Omeprazole | 48 | $1,026 | $21 |
| Venlafaxine Hcl Er | 12 | $1,019 | $85 |
| Pantoprazole | 50 | $874 | $17 |
| Synthroid | 13 | $843 | $65 |
| Ibandronate | 15 | $815 | $54 |
| Gabapentin | 51 | $803 | $16 |
| Azelastine | 11 | $793 | $72 |
| Albuterol Sulfate Hfa | 16 | $784 | $49 |
| Valsartan | 12 | $701 | $58 |
| Losartan-Hydrochlorothiazide | 15 | $689 | $46 |
| Tamsulosin | 25 | $676 | $27 |
| Sertraline | 22 | $637 | $29 |
| Metformin | 38 | $616 | $16 |
| Ondansetron | 16 | $597 | $37 |
| Alprazolam | 34 | $565 | $17 |
| Simvastatin | 30 | $480 | $16 |
| Oxybutynin Chloride | 11 | $449 | $41 |
| Escitalopram | 15 | $438 | $29 |
| Triamterene-Hydrochlorothiazid | 17 | $357 | $21 |
| Cyclobenzaprine | 25 | $353 | $14 |
| Potassium Chloride | 16 | $338 | $21 |
| Pravastatin | 14 | $304 | $22 |
| Hydrocodone-Acetaminophen | 20 | $302 | $15 |
| Metformin Hcl Er | 11 | $297 | $27 |
| Allopurinol | 12 | $264 | $22 |
| Metoprolol | 17 | $255 | $15 |
| Carvedilol | 13 | $237 | $18 |
| Hydrochlorothiazide | 55 | $220 | $4 |
| Ropinirole | 12 | $213 | $18 |
| Glipizide | 13 | $208 | $16 |
| Naproxen | 18 | $188 | $10 |
| Clopidogrel | 15 | $156 | $10 |
| Baclofen | 12 | $155 | $13 |
| Oxycodone | 13 | $145 | $11 |
| Citalopram Hbr | 14 | $143 | $10 |
| Alendronate | 11 | $134 | $12 |
| Atenolol | 20 | $120 | $6 |
| Hydroxyzine | 11 | $119 | $11 |
| Furosemide | 28 | $111 | $4 |
| Benazepril | 12 | $111 | $9 |
| Cephalexin | 14 | $84 | $6 |
| Meclizine | 11 | $80 | $7 |
| Clonazepam | 17 | $69 | $4 |
| Diazepam | 15 | $39 | $3 |
| Zolpidem | 11 | $39 | $4 |
| Lorazepam | 12 | $34 | $3 |
2020: 37 drugs
| Symbicort | 11 | $5,266 | $479 |
| Testosterone | 14 | $3,671 | $262 |
| Atorvastatin | 77 | $1,564 | $20 |
| Losartan | 54 | $1,247 | $23 |
| Levothyroxine | 46 | $1,171 | $25 |
| Amlodipine Besylate | 62 | $974 | $16 |
| Trazodone | 45 | $826 | $18 |
| Omeprazole | 24 | $777 | $32 |
| Tamsulosin | 20 | $771 | $39 |
| Metoprolol | 27 | $733 | $27 |
| Albuterol Sulfate Hfa | 13 | $601 | $46 |
| Clopidogrel | 27 | $590 | $22 |
| Azelastine | 11 | $533 | $48 |
| Venlafaxine Hcl Er | 11 | $516 | $47 |
| Gabapentin | 31 | $490 | $16 |
| Lisinopril | 34 | $466 | $14 |
| Alprazolam | 24 | $412 | $17 |
| Ropinirole | 20 | $382 | $19 |
| Sertraline | 17 | $294 | $17 |
| Escitalopram | 13 | $285 | $22 |
| Acyclovir | 15 | $280 | $19 |
| Pravastatin | 12 | $255 | $21 |
| Simvastatin | 19 | $252 | $13 |
| Pantoprazole | 24 | $247 | $10 |
| Ondansetron | 11 | $215 | $20 |
| Metformin | 21 | $208 | $10 |
| Lisinopril-Hydrochlorothiazide | 16 | $203 | $13 |
| Hydrocodone-Acetaminophen | 21 | $182 | $9 |
| Furosemide | 21 | $140 | $7 |
| Metoprolol | 13 | $108 | $8 |
| Alendronate | 12 | $108 | $9 |
| Ibuprofen | 14 | $104 | $7 |
| Hydrochlorothiazide | 22 | $90 | $4 |
| Carvedilol | 14 | $88 | $6 |
| Tramadol | 17 | $75 | $4 |
| Cyclobenzaprine | 17 | $57 | $3 |
| Atenolol | 13 | $43 | $3 |
2019: 5 drugs
| Eliquis | 26 | $11,782 | $453 |
| Clopidogrel | 49 | $568 | $12 |
| Atorvastatin | 23 | $265 | $12 |
| Metoprolol | 22 | $78 | $4 |
| Carvedilol | 12 | $70 | $6 |
2018: 5 drugs
| Eliquis | 14 | $6,860 | $490 |
| Clopidogrel | 37 | $534 | $14 |
| Atorvastatin | 19 | $248 | $13 |
| Metoprolol | 17 | $238 | $14 |
| Famotidine | 19 | $112 | $6 |
2017: 4 drugs
| Effient | 13 | $5,681 | $437 |
| Clopidogrel | 43 | $747 | $17 |
| Metoprolol | 16 | $305 | $19 |
| Atorvastatin | 20 | $170 | $8 |
2016: 9 drugs
| Effient | 13 | $8,593 | $661 |
| Clopidogrel | 58 | $1,026 | $18 |
| Atorvastatin | 35 | $418 | $12 |
| Metoprolol | 13 | $182 | $14 |
| Pantoprazole | 19 | $168 | $9 |
| Metoprolol | 37 | $127 | $3 |
| Famotidine | 14 | $70 | $5 |
| Lisinopril | 15 | $37 | $2 |
| Furosemide | 14 | $30 | $2 |
2015: 3 drugs
| Clopidogrel | 28 | $370 | $13 |
| Atorvastatin | 15 | $212 | $14 |
| Metoprolol | 21 | $119 | $6 |
2014: 2 drugs
| Clopidogrel | 37 | $691 | $19 |
| Metoprolol | 13 | $63 | $5 |
2013: 2 drugs
| Clopidogrel | 22 | $1,019 | $46 |
| Metoprolol | 11 | $505 | $46 |
Money from drug and device companies
$270 in 2025
| 2025 | 6 | 7 | None | $270 |
| 2024 | 4 | 4 | None | $90 |
| 2023 | 1 | 3 | None | $287 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $120 | 1 payment
|
| Amgen | Evenity | $50 | 2 payments
|
| Inspire Medical Systems | Inspire | $39 | 1 payment
|
| Lilly USA | Mounjaro | $26 | 1 payment
|
| Esperion Therapeutics | Nexletol | $21 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
See all 7 published payments
| Esperion Therapeutics | Meals · 2025-12-11 | Nexletol | $21 |
| Lilly USA | Meals · 2025-09-18 | Mounjaro | $26 |
| Amgen | Meals · 2025-02-20 | Evenity | $27 |
| Novo Nordisk | Meals · 2025-02-13 | Ozempic | $14 |
| Edwards Lifesciences | Meals · 2025-02-05 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $120 |
| Amgen | Meals · 2025-01-16 | Evenity | $22 |
| Inspire Medical Systems | Meals · 2025-01-09 | Inspire | $39 |
See earlier years (2024, 2023)
2024: $90
| Exact Sciences | Cologuard Collection Kit | $28 | 1 payment
|
| Novo Nordisk | Wegovy | $25 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $22 | 1 payment
|
| Abbvie | Lupron Depot | $16 | 1 payment
|
2023: $287
| Medtronic | Micra | $287 | 3 payments
|
Professional record
- NPI
- 1699858357
- Licence
- CA 14057, CA 616687
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 1705 Georgia St, Napa, CA, 94559
- NPI first listed
- 2006-10-24
- NPI last updated
- 2021-10-15
- NPI record certified
- 2021-10-15
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.